委员会实施条例(EU) 2019/1589,就延长活性成分a胺磺隆,β-氟氰菊酯,联苯菊酯,氯甲苯隆,氯芬太嗪,克洛马宗,氯氰菊酯,达米诺嗪,溴氰菊酯,麦草畏,双芬康唑,双氟苯磺隆,双氟芬尼,芬诺沙普罗-P,苯乙磺啶,氟苯乙磺酸 吲哚沙威,利那西尔,MCPA,MCPB,烟嘧磺隆,吡咯烷,原磺卡威,吡咯烷芬,甲基托布津,三氟磺隆和三甲苯磺隆的授权期,修订(EU) No 540/2011

时间: 2019-10-01


2019-09-26

OJ L 248, 27.9.2019, p. 24–27

Regulation|条例

Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (Text with EEA relevance.)

(EU) 2019/1589